Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
ETN vs EMR vs HON vs ROK vs PH
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Conglomerates
Industrial - Machinery
Industrial - Machinery
ETN vs EMR vs HON vs ROK vs PH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Conglomerates | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $163.49B | $83.18B | $137.39B | $51.65B | $113.93B |
| Revenue (TTM) | $28.52B | $18.32B | $36.76B | $8.80B | $20.99B |
| Net Income (TTM) | $3.99B | $2.44B | $4.10B | $1.09B | $3.48B |
| Gross Margin | 36.9% | 39.4% | 36.9% | 52.5% | 37.2% |
| Operating Margin | 18.1% | 19.4% | 14.9% | 19.1% | 20.9% |
| Forward P/E | 31.7x | 22.8x | 20.6x | 37.8x | 29.1x |
| Total Debt | $11.17B | $13.76B | $34.58B | $3.65B | $9.64B |
| Cash & Equiv. | $622M | $1.54B | $12.49B | $468M | $467M |
ETN vs EMR vs HON vs ROK vs PH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Eaton Corporation p… (ETN) | 100 | 496.3 | +396.3% |
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
| Honeywell Internati… (HON) | 100 | 148.7 | +48.7% |
| Rockwell Automation… (ROK) | 100 | 212.5 | +112.5% |
| Parker-Hannifin Cor… (PH) | 100 | 501.6 | +401.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ETN vs EMR vs HON vs ROK vs PH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ETN ranks third and is worth considering specifically for growth exposure.
- Rev growth 10.3%, EPS growth 10.1%, 3Y rev CAGR 9.8%
- 10.3% revenue growth vs PH's -0.4%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Lower P/E (20.6x vs 37.8x)
ROK is the clearest fit if your priority is momentum.
- +83.7% vs HON's +5.5%
PH is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 7.4% 10Y total return vs ETN's 6.4%
- PEG 1.22 vs HON's 11.22
- 16.6% margin vs HON's 11.2%
- 11.5% ROA vs HON's 5.3%, ROIC 13.4% vs 12.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs PH's -0.4% | |
| Value | Lower P/E (20.6x vs 37.8x) | |
| Quality / Margins | 16.6% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.4% | |
| Momentum (1Y) | +83.7% vs HON's +5.5% | |
| Efficiency (ROA) | 11.5% ROA vs HON's 5.3%, ROIC 13.4% vs 12.6% |
ETN vs EMR vs HON vs ROK vs PH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ETN vs EMR vs HON vs ROK vs PH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PH leads in 2 of 6 categories
HON leads 1 • ROK leads 1 • ETN leads 0 • EMR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 4.2x ROK's $8.8B. PH is the more profitable business, keeping 16.6% of every revenue dollar as net income compared to HON's 11.2%. On growth, ETN holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $28.5B | $18.3B | $36.8B | $8.8B | $21.0B |
| EBITDAEarnings before interest/tax | $5.9B | $4.7B | $6.5B | $1.9B | $5.1B |
| Net IncomeAfter-tax profit | $4.0B | $2.4B | $4.1B | $1.1B | $3.5B |
| Free Cash FlowCash after capex | $4.7B | $3.1B | $4.2B | $1.3B | $3.7B |
| Gross MarginGross profit ÷ Revenue | +36.9% | +39.4% | +36.9% | +52.5% | +37.2% |
| Operating MarginEBIT ÷ Revenue | +18.1% | +19.4% | +14.9% | +19.1% | +20.9% |
| Net MarginNet income ÷ Revenue | +14.0% | +13.3% | +11.2% | +12.4% | +16.6% |
| FCF MarginFCF ÷ Revenue | +16.5% | +17.0% | +11.4% | +15.2% | +17.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.8% | +2.9% | -6.9% | +11.8% | +10.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -9.4% | +28.2% | -41.9% | +39.6% | -4.2% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.5x trailing earnings, HON trades at a 51% valuation discount to ROK's 59.9x P/E. Adjusting for growth (PEG ratio), PH offers better value at 1.39x vs HON's 16.04x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $163.5B | $83.2B | $137.4B | $51.6B | $113.9B |
| Enterprise ValueMkt cap + debt − cash | $174.0B | $95.4B | $159.5B | $54.8B | $123.1B |
| Trailing P/EPrice ÷ TTM EPS | 40.29x | 36.61x | 29.46x | 59.89x | 33.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.67x | 22.77x | 20.60x | 37.84x | 29.11x |
| PEG RatioP/E ÷ EPS growth rate | 1.64x | 8.11x | 16.04x | — | 1.39x |
| EV / EBITDAEnterprise value multiple | 29.10x | 18.89x | 20.05x | 31.36x | 24.78x |
| Price / SalesMarket cap ÷ Revenue | 5.96x | 4.62x | 3.67x | 6.19x | 5.74x |
| Price / BookPrice ÷ Book value/share | 8.43x | 4.13x | 9.03x | 14.00x | 8.58x |
| Price / FCFMarket cap ÷ FCF | 36.56x | 31.19x | 25.48x | 38.03x | 34.10x |
Profitability & Efficiency
ROK leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $12 for EMR. ETN carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.8% | +12.1% | +23.1% | +29.6% | +24.3% |
| ROA (TTM)Return on assets | +9.0% | +5.8% | +5.3% | +9.7% | +11.5% |
| ROICReturn on invested capital | +13.6% | +8.2% | +12.6% | +15.1% | +13.4% |
| ROCEReturn on capital employed | +16.8% | +10.0% | +12.6% | +18.5% | +17.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 6 | 8 | 8 |
| Debt / EquityFinancial leverage | 0.57x | 0.68x | 2.24x | 0.98x | 0.70x |
| Net DebtTotal debt minus cash | $10.5B | $12.2B | $22.1B | $3.2B | $9.2B |
| Cash & Equiv.Liquid assets | $622M | $1.5B | $12.5B | $468M | $467M |
| Total DebtShort + long-term debt | $11.2B | $13.8B | $34.6B | $3.6B | $9.6B |
| Interest CoverageEBIT ÷ Interest expense | 16.38x | 6.61x | 3.92x | 9.06x | 11.39x |
Total Returns (Dividends Reinvested)
PH leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ETN five years ago would be worth $30,003 today (with dividends reinvested), compared to $10,364 for HON. Over the past 12 months, ROK leads with a +83.7% total return vs HON's +5.5%. The 3-year compound annual growth rate (CAGR) favors PH at 40.2% vs HON's 5.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.1% | +9.3% | +11.3% | +15.6% | +1.2% |
| 1-Year ReturnPast 12 months | +42.4% | +39.9% | +5.5% | +83.7% | +48.2% |
| 3-Year ReturnCumulative with dividends | +154.4% | +84.1% | +16.6% | +68.9% | +175.4% |
| 5-Year ReturnCumulative with dividends | +200.0% | +69.0% | +3.6% | +80.1% | +194.8% |
| 10-Year ReturnCumulative with dividends | +637.5% | +215.5% | +134.6% | +347.3% | +741.1% |
| CAGR (3Y)Annualised 3-year return | +36.5% | +22.6% | +5.2% | +19.1% | +40.2% |
Risk & Volatility
Evenly matched — HON and ROK each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 99.1% from its 52-week high vs PH's 87.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.42x | 1.52x | 0.74x | 1.33x | 1.00x |
| 52-Week HighHighest price in past year | $435.43 | $165.15 | $248.18 | $463.49 | $1034.96 |
| 52-Week LowLowest price in past year | $296.09 | $106.53 | $186.76 | $250.32 | $608.31 |
| % of 52W HighCurrent price vs 52-week peak | +96.8% | +89.6% | +87.4% | +99.1% | +87.2% |
| RSI (14)Momentum oscillator 0–100 | 55.1 | 48.4 | 32.3 | 68.9 | 33.9 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 2.8M | 3.7M | 836K | 710K |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ETN as "Buy", EMR as "Buy", HON as "Buy", ROK as "Hold", PH as "Buy". Consensus price targets imply 15.4% upside for PH (target: $1042) vs -9.9% for ETN (target: $380). For income investors, HON offers the higher dividend yield at 2.14% vs PH's 0.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $379.78 | $161.92 | $243.83 | $436.56 | $1042.08 |
| # AnalystsCovering analysts | 39 | 41 | 28 | 39 | 38 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +1.4% | +2.1% | +1.1% | +0.7% |
| Dividend StreakConsecutive years of raises | 24 | 37 | 15 | 20 | 33 |
| Dividend / ShareAnnual DPS | $4.17 | $2.10 | $4.63 | $5.23 | $6.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +1.5% | +2.8% | +0.8% | +1.5% |
PH leads in 2 of 6 categories (Income & Cash Flow, Total Returns). HON leads in 1 (Valuation Metrics). 2 tied.
ETN vs EMR vs HON vs ROK vs PH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ETN or EMR or HON or ROK or PH a better buy right now?
For growth investors, Eaton Corporation plc (ETN) is the stronger pick with 10.
3% revenue growth year-over-year, versus -0. 4% for Parker-Hannifin Corporation (PH). Honeywell International Inc. (HON) offers the better valuation at 29. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Eaton Corporation plc (ETN) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ETN or EMR or HON or ROK or PH?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 5x versus Rockwell Automation, Inc. at 59. 9x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Parker-Hannifin Corporation wins at 1. 22x versus Honeywell International Inc. 's 11. 22x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — ETN or EMR or HON or ROK or PH?
Over the past 5 years, Eaton Corporation plc (ETN) delivered a total return of +200.
0%, compared to +3. 6% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: PH returned +741. 1% versus HON's +134. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ETN or EMR or HON or ROK or PH?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Eaton Corporation plc (ETN) carries a lower debt/equity ratio of 57% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ETN or EMR or HON or ROK or PH?
By revenue growth (latest reported year), Eaton Corporation plc (ETN) is pulling ahead at 10.
3% versus -0. 4% for Parker-Hannifin Corporation (PH). On earnings-per-share growth, the picture is similar: Parker-Hannifin Corporation grew EPS 24. 2% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, ETN leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ETN or EMR or HON or ROK or PH?
Parker-Hannifin Corporation (PH) is the more profitable company, earning 17.
8% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PH leads at 20. 5% versus 17. 1% for ROK. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ETN or EMR or HON or ROK or PH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Parker-Hannifin Corporation (PH) is the more undervalued stock at a PEG of 1. 22x versus Honeywell International Inc. 's 11. 22x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 6x forward P/E versus 37. 8x for Rockwell Automation, Inc. — 17. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PH: 15. 4% to $1042. 08.
08Which pays a better dividend — ETN or EMR or HON or ROK or PH?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 7% for Parker-Hannifin Corporation (PH).
09Is ETN or EMR or HON or ROK or PH better for a retirement portfolio?
For long-horizon retirement investors, Parker-Hannifin Corporation (PH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
00), 0. 7% yield, +741. 1% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PH: +741. 1%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ETN and EMR and HON and ROK and PH?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.